RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

The patient in this case had suffered acute liver failure following the Elevidys infusion. Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy (DMD) who received Elevidys ...